周五聚焦——口服SERDs瞄准早期机遇，Agios镰状细胞病药物受挫，Avadel不眠竞价战及其他——FirstWord Pharma

Friday Five — Oral SERDs eye earlier opportunities, Agios' SCD miss, Avadel's not-so-sleepy bidding war…and more  FirstWord Pharma